NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular Medicine Reports

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/mmr.2016.5034PMID 27035562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental Models of Parkinson’s Disease

  2021cited by this paper
• Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson’s disease

  2014cited by this paper
• A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-κB and the PKCα/PI3-K/Akt pathways.

  2014cited by this paper
• 7,8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cell death through modulating PI3K/Akt and JNK pathways.

  2014cited by this paper
• Carvedilol Attenuates 6-Hydroxydopamine-Induced Cell Death in PC12 Cells: Involvement of Akt and Nrf2/ARE Pathways

  2014cited by this paper
• Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease

  2013cited by this paper
• Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention.

  2012cited by this paper
• SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions.

  2010cited by this paper
• Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure*

  2010cited by this paper
• Parkinson’s disease: oxidative stress and therapeutic approaches

  2010cited by this paper
• The critical role of the class III histone deacetylase SIRT1 in cancer.

  2009cited by this paper
• Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression.

  2008cited by this paper
• The 6-hydroxydopamine model: news from the past.

  2008cited by this paper
• Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging.

  2008cited by this paper
• NAD+/NADH and NADP+/NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences

  2008cited by this paper
• The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals

  2007cited by this paper
• Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

  2007cited by this paper
• SIRT1 promotes DNA repair activity and deacetylation of Ku70

  2007cited by this paper
• Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action.

  2007cited by this paper
• Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway.

  2006cited by this paper
• Oxidative stress and neurodegeneration: where are we now?

  2006cited by this paper
• 6-Hydroxydopamine-induced Apoptosis Is Mediated via Extracellular Auto-oxidation and Caspase 3-dependent Activation of Protein Kinase Cδ*

  2006cited by this paper
• NAD metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity

  2006cited by this paper
• H2O2 Accelerates Cellular Senescence by Accumulation of Acetylated p53 via Decrease in the Function of SIRT1 by NAD+ Depletion

  2006cited by this paper
• Poly(ADP‐ribose)

  2005cited by this paper
• Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.

  2005cited by this paper
• The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells*

  2004cited by this paper
• Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP

  2004cited by this paper
• Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration

  2004cited by this paper
• Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase

  2004cited by this paper
• Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis

  2002cited by this paper
• Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

  2001cited by this paper
• Experimental models of Parkinson's disease

  2001cited by this paper
• Autoxidation and Neurotoxicity of 6‐Hydroxydopamine in the Presence of Some Antioxidants

  2000cited by this paper
• Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

  2000cited by this paper
• Transcriptional silencing and longevity protein Sir 2 is an NAD-dependent histone deacetylase

  year unknowncited by this paper

• Autophagy–NAD+ axis: emerging insights into neuronal homeostasis and neurodegenerative diseases

  2025cites this paper
• Sirtuin dysregulation in Parkinson's disease: Implications of acetylation and deacetylation processes.

  2024cites this paper
• Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson’s Disease Patients with and without Dyskinesia: A Preliminary Examination

  2024cites this paper
• Intranasal AdipoRon Mitigated Anxiety and Depression-Like Behaviors in 6-OHDA-Induced Parkinson ’s Disease Rat Model: Going Beyond Motor Symptoms

  2024cites this paper
• Ablation of NAMPT in dopaminergic neurons leads to neurodegeneration and induces Parkinson's disease in mouse.

  2024cites this paper
• The versatile multi-functional substance NMN: its unique characteristics, metabolic properties, pharmacodynamic effects, clinical trials, and diverse applications

  2024cites this paper
• Potential Therapeutic Interventions Targeting NAD+ Metabolism for ALS

  2024cites this paper
• Technology and functional insights into the nicotinamide mononucleotide for human health

  2023cites this paper
• COA-Cl Evokes Protective Responses Against H2O2-and 6-OHDA-Induced Toxic Injury in PC12 Cells

  2022cites this paper
• Brain Region and Sex-specific Changes in Mitochondrial Biogenesis Induced by Acute Trimethyltin Exposure

  2022cites this paper
• Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson’s Disease: a Systematic Review

  2022cites this paper
• Multifaced role of protein deacetylase sirtuins in neurodegenerative disease.

  2021cites this paper
• Progresses in both basic research and clinical trials of NAD+ in Parkinson's disease.

  2021cites this paper
• NAD+ Metabolism and Diseases with Motor Dysfunction

  2021cites this paper
• SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases

  2021cites this paper
• NAD+: a crucial regulator of sirtuin activity in aging

  2021cites this paper
• The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations

  2020cites this paper
• Kars region of Turkey: The role of computerized temporal tomography in diagnosis of tympanosclerosis

  2020cites this paper
• Protective effects of nicotinamide mononucleotide against oxidative stress-induced PC12 cell death via mitochondrial enhancement

  2020cites this paper
• Nicotinamide mononucleotide treatment increases NAD+ levels in an iPSC Model of Parkinson’s Disease

  2020cites this paper
• Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson’s Disease Model Induced by 6-OHDA

  2020cites this paper
• Anti-apoptotic and anti-inflammatory activity of Gentiana lutea root extract

  2020cites this paper
• Notoginseng Leaf Triterpenes Ameliorates OGD/R-Induced Neuronal Injury via SIRT1/2/3-Foxo3a-MnSOD/PGC-1α Signaling Pathways Mediated by the NAMPT-NAD Pathway

  2020cites this paper
• Notoginseng leaf triterpenes ameliorates mitochondrial oxidative injury via the NAMPT-SIRT1/2/3 signaling pathways in cerebral ischemic model rats

  2020cites this paper
• Nicotinamide and Demographic and Disease transitions: Moderation is Best

  2019cites this paper
• Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress

  2018cites this paper
• Wine Polyphenols and Neurodegenerative Diseases: An Update on the Molecular Mechanisms Underpinning Their Protective Effects

  2018cites this paper
• Sirtuins as Modifiers of Huntington's Disease (HD) Pathology.

  2018cites this paper
• SIRT1 mediates salidroside‐elicited protective effects against MPP+‐induced apoptosis and oxidative stress in SH‐SY5Y cells: involvement in suppressing MAPK pathways

  2018cites this paper
• Meat Intake and the Dose of Vitamin B3 – Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?

  2017cites this paper
• Sirtuins as modifiers of Parkinson's disease pathology

  2017cites this paper
• Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology

  2017cites this paper
• Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

  2017cites this paper
• University of Birmingham Meat Intake and the Dose of Vitamin B3 Nicotinamide

  2017cites this paper
• Metabolic Disorder Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism

  2017cites this paper
• Biological and Clinical Implications of Comorbidities in Parkinson’s Disease

  2017cites this paper
• Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease

  2016cites this paper